Meniere's disease. 2016

Tsutomu Nakashima, and Ilmari Pyykkö, and Megan A Arroll, and Margaretha L Casselbrant, and Carol A Foster, and Nauman F Manzoor, and Cliff A Megerian, and Shinji Naganawa, and Yi-Ho Young
Department of Rehabilitation, Ichinomiya Medical Treatment &Habilitation Center, 1679-2, Tomida-nagaresuji, Ichinomiya City, 494-0018, Japan.

Meniere's disease (MD) is a disorder of the inner ear that causes vertigo attacks, fluctuating hearing loss, tinnitus and aural fullness. The aetiology of MD is multifactorial. A characteristic sign of MD is endolymphatic hydrops (EH), a disorder in which excessive endolymph accumulates in the inner ear and causes damage to the ganglion cells. In most patients, the clinical symptoms of MD present after considerable accumulation of endolymph has occurred. However, some patients develop symptoms in the early stages of EH. The reason for the variability in the symptomatology is unknown and the relationship between EH and the clinical symptoms of MD requires further study. The diagnosis of MD is based on clinical symptoms but can be complemented with functional inner ear tests, including audiometry, vestibular-evoked myogenic potential testing, caloric testing, electrocochleography or head impulse tests. MRI has been optimized to directly visualize EH in the cochlea, vestibule and semicircular canals, and its use is shifting from the research setting to the clinic. The management of MD is mainly aimed at the relief of acute attacks of vertigo and the prevention of recurrent attacks. Therapeutic options are based on empirical evidence and include the management of risk factors and a conservative approach as the first line of treatment. When medical treatment is unable to suppress vertigo attacks, intratympanic gentamicin therapy or endolymphatic sac decompression surgery is usually considered. This Primer covers the pathophysiology, symptomatology, diagnosis, management, quality of life and prevention of MD.

UI MeSH Term Description Entries
D007758 Ear, Inner The essential part of the hearing organ consists of two labyrinthine compartments: the bony labyrinthine and the membranous labyrinth. The bony labyrinth is a complex of three interconnecting cavities or spaces (COCHLEA; VESTIBULAR LABYRINTH; and SEMICIRCULAR CANALS) in the TEMPORAL BONE. Within the bony labyrinth lies the membranous labyrinth which is a complex of sacs and tubules (COCHLEAR DUCT; SACCULE AND UTRICLE; and SEMICIRCULAR DUCTS) forming a continuous space enclosed by EPITHELIUM and connective tissue. These spaces are filled with LABYRINTHINE FLUIDS of various compositions. Labyrinth,Bony Labyrinth,Ear, Internal,Inner Ear,Membranous Labyrinth,Bony Labyrinths,Ears, Inner,Ears, Internal,Inner Ears,Internal Ear,Internal Ears,Labyrinth, Bony,Labyrinth, Membranous,Labyrinths,Labyrinths, Bony,Labyrinths, Membranous,Membranous Labyrinths
D008279 Magnetic Resonance Imaging Non-invasive method of demonstrating internal anatomy based on the principle that atomic nuclei in a strong magnetic field absorb pulses of radiofrequency energy and emit them as radiowaves which can be reconstructed into computerized images. The concept includes proton spin tomographic techniques. Chemical Shift Imaging,MR Tomography,MRI Scans,MRI, Functional,Magnetic Resonance Image,Magnetic Resonance Imaging, Functional,Magnetization Transfer Contrast Imaging,NMR Imaging,NMR Tomography,Tomography, NMR,Tomography, Proton Spin,fMRI,Functional Magnetic Resonance Imaging,Imaging, Chemical Shift,Proton Spin Tomography,Spin Echo Imaging,Steady-State Free Precession MRI,Tomography, MR,Zeugmatography,Chemical Shift Imagings,Echo Imaging, Spin,Echo Imagings, Spin,Functional MRI,Functional MRIs,Image, Magnetic Resonance,Imaging, Magnetic Resonance,Imaging, NMR,Imaging, Spin Echo,Imagings, Chemical Shift,Imagings, Spin Echo,MRI Scan,MRIs, Functional,Magnetic Resonance Images,Resonance Image, Magnetic,Scan, MRI,Scans, MRI,Shift Imaging, Chemical,Shift Imagings, Chemical,Spin Echo Imagings,Steady State Free Precession MRI
D008468 Meclizine A histamine H1 antagonist used in the treatment of motion sickness, vertigo, and nausea during pregnancy and radiation sickness. Histametizyn,Meclozine,Parachloramine,Agyrax,Antivert,Bonamine,Bonine,Chiclida,D-Vert,Meclizine Dihydrochloride,Meclizine Hydrochloride,Meclizine Monohydrochloride,Ru-Vert-M,D Vert,DVert,Dihydrochloride, Meclizine,Hydrochloride, Meclizine,Monohydrochloride, Meclizine,Ru Vert M
D008575 Meniere Disease A disease of the inner ear (LABYRINTH) that is characterized by fluctuating SENSORINEURAL HEARING LOSS; TINNITUS; episodic VERTIGO; and aural fullness. It is the most common form of endolymphatic hydrops. Meniere's Disease,Meniere's Syndrome,Vertigo, Aural,Auditory Vertigo,Aural Vertigo,Ménière Disease,Ménière's Disease,Ménière's Vertigo,Otogenic Vertigo,Auditory Vertigos,Disease, Meniere,Disease, Meniere's,Disease, Ménière,Disease, Ménière's,Diseases, Ménière,Diseases, Ménière's,Meniere Syndrome,Menieres Disease,Menieres Syndrome,Ménière Diseases,Ménière Vertigo,Ménière's Diseases,Ménière's Vertigos,Ménières Disease,Ménières Vertigo,Otogenic Vertigos,Syndrome, Meniere's,Vertigo, Auditory,Vertigo, Ménière's,Vertigo, Otogenic,Vertigos, Auditory,Vertigos, Ménière's,Vertigos, Otogenic
D011398 Promethazine A phenothiazine derivative with histamine H1-blocking, antimuscarinic, and sedative properties. It is used as an antiallergic, in pruritus, for motion sickness and sedation, and also in animals. Proazamine,Atosil,Diphergan,Diprazin,Isopromethazine,Phenargan,Phenergan,Phensedyl,Pipolfen,Pipolphen,Promet,Prometazin,Promethazine Hydrochloride,Prothazin,Pyrethia,Remsed,Rumergan,Hydrochloride, Promethazine
D011788 Quality of Life A generic concept reflecting concern with the modification and enhancement of life attributes, e.g., physical, political, moral, social environment as well as health and disease. HRQOL,Health-Related Quality Of Life,Life Quality,Health Related Quality Of Life
D004111 Dimenhydrinate A drug combination that contains diphenhydramine and theophylline. It is used for treating VERTIGO, MOTION SICKNESS, and NAUSEA associated with PREGNANCY. Diphenhydramine Theoclate,Apo-Dimenhydrinate,Aviomarin,Biodramina,Calm-X,Cinfamar,Contramareo,DMH,Dimen Heumann,Dimen Lichtenstein,Dimetabs,Dinate,Dramamine,Dramanate,Gravol,Marmine,Motion-Aid,Nausicalm,Reisegold,Reisetabletten Lünopharm,Reisetabletten Stada,Reisetabletten-ratiopharm,Rodovan,RubieMen,Superpep,Travel Well,TripTone,Vertigo-Vomex,Vomacur,Vomex A,Vomisin,Wehamine,Apo Dimenhydrinate,Calm X,Heumann, Dimen,Lichtenstein, Dimen,Lünopharm, Reisetabletten,Motion Aid,Reisetabletten ratiopharm,Stada, Reisetabletten,Theoclate, Diphenhydramine,Vertigo Vomex
D004710 Endolymph The lymph fluid found in the membranous labyrinth of the ear. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Endolymphs
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000932 Antiemetics Drugs used to prevent NAUSEA or VOMITING. Anti-emetic,Antiemetic,Antiemetic Agent,Antiemetic Drug,Anti-Emetic Effect,Anti-Emetic Effects,Anti-emetics,Antiemetic Agents,Antiemetic Drugs,Antiemetic Effect,Antiemetic Effects,Agent, Antiemetic,Agents, Antiemetic,Anti Emetic Effect,Anti Emetic Effects,Anti emetic,Anti emetics,Drug, Antiemetic,Drugs, Antiemetic,Effect, Anti-Emetic,Effect, Antiemetic,Effects, Anti-Emetic,Effects, Antiemetic

Related Publications

Tsutomu Nakashima, and Ilmari Pyykkö, and Megan A Arroll, and Margaretha L Casselbrant, and Carol A Foster, and Nauman F Manzoor, and Cliff A Megerian, and Shinji Naganawa, and Yi-Ho Young
November 1971, Nihon rinsho. Japanese journal of clinical medicine,
Tsutomu Nakashima, and Ilmari Pyykkö, and Megan A Arroll, and Margaretha L Casselbrant, and Carol A Foster, and Nauman F Manzoor, and Cliff A Megerian, and Shinji Naganawa, and Yi-Ho Young
November 1958, Eye, ear, nose & throat monthly,
Tsutomu Nakashima, and Ilmari Pyykkö, and Megan A Arroll, and Margaretha L Casselbrant, and Carol A Foster, and Nauman F Manzoor, and Cliff A Megerian, and Shinji Naganawa, and Yi-Ho Young
July 1963, Archives of otolaryngology (Chicago, Ill. : 1960),
Tsutomu Nakashima, and Ilmari Pyykkö, and Megan A Arroll, and Margaretha L Casselbrant, and Carol A Foster, and Nauman F Manzoor, and Cliff A Megerian, and Shinji Naganawa, and Yi-Ho Young
August 1971, Das Deutsche Gesundheitswesen,
Tsutomu Nakashima, and Ilmari Pyykkö, and Megan A Arroll, and Margaretha L Casselbrant, and Carol A Foster, and Nauman F Manzoor, and Cliff A Megerian, and Shinji Naganawa, and Yi-Ho Young
September 1963, Journal of the Oto-laryngological Society of Australia,
Tsutomu Nakashima, and Ilmari Pyykkö, and Megan A Arroll, and Margaretha L Casselbrant, and Carol A Foster, and Nauman F Manzoor, and Cliff A Megerian, and Shinji Naganawa, and Yi-Ho Young
May 2016, Nature reviews. Disease primers,
Tsutomu Nakashima, and Ilmari Pyykkö, and Megan A Arroll, and Margaretha L Casselbrant, and Carol A Foster, and Nauman F Manzoor, and Cliff A Megerian, and Shinji Naganawa, and Yi-Ho Young
November 1948, The Journal of laryngology and otology,
Tsutomu Nakashima, and Ilmari Pyykkö, and Megan A Arroll, and Margaretha L Casselbrant, and Carol A Foster, and Nauman F Manzoor, and Cliff A Megerian, and Shinji Naganawa, and Yi-Ho Young
March 1974, The Journal of the American Osteopathic Association,
Tsutomu Nakashima, and Ilmari Pyykkö, and Megan A Arroll, and Margaretha L Casselbrant, and Carol A Foster, and Nauman F Manzoor, and Cliff A Megerian, and Shinji Naganawa, and Yi-Ho Young
February 1971, Kangogaku zasshi,
Tsutomu Nakashima, and Ilmari Pyykkö, and Megan A Arroll, and Margaretha L Casselbrant, and Carol A Foster, and Nauman F Manzoor, and Cliff A Megerian, and Shinji Naganawa, and Yi-Ho Young
October 1959, Maryland state medical journal,
Copied contents to your clipboard!